• CTS Announces Fourth Quarter and Full Year 2021 Results

    Источник: Nasdaq GlobeNewswire / 08 фев 2022 07:30:01   America/New_York

    LISLE, Ill., Feb. 08, 2022 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “sense, connect and move” today announced fourth quarter and full year 2021 results.

    “We delivered strong growth across all end markets despite a challenging macroeconomic environment. Importantly, we also further advanced our diversification strategy, which was underscored by a 25% increase in non-transportation revenues over the previous year, while at the same time winning record new business across end markets,” said Kieran O’Sullivan, CEO of CTS Corporation.

    “We enter 2022 with a goal to continue our progress on profitable growth and diversification. The investments we’ve made in the business combined with our strong balance sheet and disciplined capital allocation approach will enable us to capitalize on future growth opportunities and continue to return value to our shareholders.”

    Fourth Quarter 2021 Results

    • Sales were $132.5 million, up 8% year-over-year. Sales to non-transportation end markets increased 25%, and sales to the transportation end market decreased 3% over the same period.
    • Net income was $9.2 million, or $0.28 per diluted share, compared to $14.9 million, or $0.46 per diluted share, in the fourth quarter of 2020. The lower net income was due to increased foreign exchange expense and a higher tax rate.
    • Adjusted diluted EPS was $0.49, up from $0.43 in the fourth quarter of 2020.
    • Adjusted EBITDA margin was 20.9% compared to 21.4% in the fourth quarter of 2020.
    • Operating cash flow was $26.0 million, compared to $26.4 million in the fourth quarter of 2020.
    • New business wins were $185 million, up from $104 million in the fourth quarter of 2020.

    Full Year 2021 Results

    • Sales were $512.9 million, up 21% year-over-year. Sales to non-transportation end markets increased 25%, and sales to the transportation end market increased 18% over the same period.
    • Net loss was $41.9 million, or $(1.30) per diluted share, versus net earnings of $34.7 million, or $1.06 per diluted share, in 2020. The 2021 net earnings were impacted by non-cash charges of $96.6 million, net of taxes related to the previously disclosed termination of the U.S. pension plan.
    • Adjusted diluted EPS was $1.93, up from $1.12 in 2020.
    • Adjusted EBITDA margin was 21.0% compared to 18.3% for 2020.
    • Operating cash flow was $86.1 million, up from $76.8 million in 2020.
    • New business wins were $694 million, up from $442 million in 2020.

    2022 Guidance

    CTS expects full year 2022 sales to be in the range of $525 – $550 million and adjusted diluted EPS in the range of $2.00 – $2.25.

    Conference Call and Supplemental Materials

    As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EST) today to discuss the fourth quarter and full year 2021 financial results. The dial-in number for the U.S. and Canada is 844-200-6205 (+1 929-526-1599, if calling from outside the U.S.). The passcode is 160107. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://www.ctscorp.com/investors/events-presentations/

    About CTS

    CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

    Safe Harbor

    This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect CTS’ current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause CTS’ actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: the ultimate impact of the COVID-19 pandemic on CTS’ business, results of operations or financial condition; changes in the economy generally and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation industry, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; and risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update its forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

    Non-GAAP Financial Measures

    From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS’ management believes that non-GAAP financial measures can be useful to investors in analyzing CTS’ financial performance and results of operations over time. CTS recommends that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.

    The information included in this press release includes the non-GAAP financial measures of adjusted operating earnings, adjusted EBITDA, adjusted net earnings, adjusted diluted earnings per share, debt to capitalization ratio, controllable working capital ratio, and free cash flow. Many of these non-GAAP financial measures exclude the effect of certain expenses and income not related directly to the underlying performance of CTS’ fundamental business operations.

    CTS believes that adjusted operating earnings, adjusted EBITDA, adjusted net earnings and, adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations or were not part of CTS’ business operations during a comparable period.

    CTS believes that debt to capitalization ratio is a measurement of financial leverage and provides an insight into the financial structure of CTS and its financial strength. CTS believes the controllable working capital ratio provides an objective measure of the efficiency with which CTS manages its short-term capital needs. CTS believes that free cash flow is a useful measure of its ability to generate cash.

    CTS believes that these non-GAAP financial measures are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. Note that CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies.

    CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

    Contact

    Ashish Agrawal
    Vice President and Chief Financial Officer
    CTS Corporation
    4925 Indiana Avenue
    Lisle, IL 60532 USA
    +1 (630) 577-8800
    ashish.agrawal@ctscorp.com

    CTS CORPORATION AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - UNAUDITED
    (In thousands of dollars, except per share amounts)

     Three Months Ended  Twelve Months Ended 
     December 31,
    2021
      December 31,
    2020
      December 31,
    2021
      December 31,
    2020
     
    Net sales$132,531  $123,018  $512,925  $424,066 
    Cost of goods sold 83,860   80,327   328,306   285,003 
    Gross margin 48,671   42,691   184,619   139,063 
    Selling, general and administrative expenses 23,413   19,476   82,597   67,787 
    Research and development expenses 5,686   5,664   23,856   24,317 
    Restructuring charges 1,136   414   1,687   1,830 
    Operating earnings 18,436   17,137   76,479   45,129 
    Other (expense) income:               
    Interest expense (534)  (655)  (2,111)  (3,272)
    Interest income 151   195   840   1,047 
    Other (expense) income, net (3,302)  2,682   (136,088)  2,575 
    Total other (expense) income, net (3,685)  2,222   (137,359)  350 
    Earnings (loss) before income taxes 14,751   19,359   (60,880)  45,479 
    Income tax expense (benefit) 5,586   4,412   (19,014)  10,793 
    Net earnings (loss) 9,165   14,947   (41,866) $34,686 
    Earnings (loss) per share:               
    Basic$0.28  $0.46  $(1.30) $1.07 
    Diluted$0.28  $0.46  $(1.30) $1.06 
    Basic weighted – average common shares outstanding: 32,214   32,273   32,327   32,317 
    Effect of dilutive securities 218   289      267 
    Diluted weighted – average common shares outstanding: 32,432   32,562   32,327   32,584 
    Cash dividends declared per share$0.04  $0.04  $0.16  $0.16 



    CTS CORPORATION AND SUBSIDIARIES
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (In thousands of dollars)

     (Unaudited)     
     December 31,
    2021
      December 31,
    2020
     
    ASSETS       
    Current Assets       
    Cash and cash equivalents$141,465  $91,773 
    Accounts receivable, net 82,191   80,981 
    Inventories, net 49,506   45,870 
    Other current assets 15,927   14,607 
    Total current assets 289,089   233,231 
    Property, plant and equipment, net 96,876   97,437 
    Operating lease assets, net 21,594   23,281 
    Other Assets       
    Prepaid pension asset 49,382   56,642 
    Goodwill 109,798   109,497 
    Other intangible assets, net 69,888   79,121 
    Deferred income taxes 25,415   24,250 
    Other 2,420   2,590 
    Total other assets 256,903   272,100 
    Total Assets$664,462  $626,049 
    LIABILITIES AND SHAREHOLDERS’ EQUITY       
    Current Liabilities       
    Accounts payable$55,537  $50,489 
    Operating lease obligations 3,393   3,294 
    Accrued payroll and benefits 18,418   12,978 
    Accrued expenses and other liabilities 36,718   38,171 
    Total current liabilities 114,066   104,932 
    Long-term debt 50,000   54,600 
    Long-term operating lease obligations 21,354   23,163 
    Long-term pension obligations 6,886   7,466 
    Deferred income taxes 5,894   7,010 
    Other long-term obligations 2,684   5,196 
    Total Liabilities 200,884   202,367 
    Commitments and Contingencies       
    Shareholders’ Equity       
    Common stock 314,620   311,190 
    Additional contributed capital 42,549   41,654 
    Retained earnings 492,242   539,281 
    Accumulated other comprehensive loss (4,525)  (95,921)
    Total shareholders’ equity before treasury stock 844,886   796,204 
    Treasury stock (381,308)  (372,522)
    Total shareholders’ equity 463,578   423,682 
    Total Liabilities and Shareholders’ Equity$664,462  $626,049 



    CTS CORPORATION AND SUBSIDIARIES
    OTHER SUPPLEMENTAL INFORMATION - UNAUDITED
    (In millions of dollars, except per share amounts)

    Adjusted Operating Earnings

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020  2019 
    Operating earnings$18.4  $17.1  $76.5  $45.1  $53.8 
    Adjustments to reported operating earnings:                   
    Restructuring charges 1.1   0.4   1.7   1.8   7.4 
    Environmental charges 1.4   1.5   2.3   2.8   2.3 
    Legal settlement             (0.5)
    Transaction costs    0.3      0.3   0.7 
    Costs of tax improvement initiatives             0.1 
    Total adjustments to reported operating earnings$2.5  $2.2  $3.9  $4.9  $10.0 
                        
    Adjusted operating earnings$21.0  $19.4  $80.4  $50.0  $63.8 
                        
    Net sales$132.5  $123.0  $512.9  $424.1  $469.0 
                        
    Adjusted operating earnings as a % of net sales 15.8%  15.7%  15.7%  11.8%  13.6%



    Adjusted EBITDA

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020  2019 
    Net earnings (loss)$9.2  $14.9  $(41.9) $34.7  $36.1 
                        
    Depreciation and amortization expense 6.7   6.9   26.9   26.7   24.6 
    Interest expense 0.5   0.7   2.1   3.3   2.6 
    Tax expense (benefit) 5.6   4.4   (19.0)  10.8   14.1 
                        
    EBITDA 22.0   26.9   (31.8)  75.4   77.5 
                        
    Adjustments to EBITDA:                   
    Restructuring charges 1.1   0.4   1.7   1.8   6.9 
    Environmental charges 1.4   1.5   2.3   2.8   2.3 
    Legal settlement             (0.5)
    Transaction costs    0.3      0.3   0.7 
    Costs of tax improvement initiatives             0.1 
    Non-cash pension expense 1.3   0.6   132.4   2.5   0.8 
    Foreign currency loss (gain) 1.9   (3.4)  3.3   (5.3)  1.8 
                        
    Total adjustments to EBITDA 5.7   (0.5)  139.7   2.1   12.0 
                        
    Adjusted EBITDA$27.7  $26.5  $107.8  $77.5  $89.5 
                        
    Net sales$132.5  $123.0  $512.9  $424.1  $469.0 
                        
    Adjusted EBITDA as a % of net sales 20.9%  21.4%  21.0%  18.3%  19.1%



    Adjusted Net Earnings

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020  2019 
    Net earnings (loss) (A)$9.2  $14.9  $(41.9) $34.7  $36.1 
    Adjustments to reported net earnings (loss):                   
    Restructuring charges 1.1   0.4   1.7   1.8   7.4 
    Environmental charges 1.4   1.5   2.3   2.8   2.3 
    Legal settlement             (0.5)
    Transaction costs    0.3      0.3   0.7 
    Costs of tax improvement initiatives             0.1 
    Non-cash pension expense 1.3   0.6   132.4   2.5   0.8 
    Foreign currency (gain) loss 1.9   (3.4)  3.3   (5.3)  1.8 
    Total adjustments to reported net earnings (loss)$5.7  $(0.5) $139.7  $2.1  $12.6 
    Total adjustments, tax affected (B)$5.1  $(1.2) $108.6  $0.4  $10.2 
                        
    Tax adjustments:                   
    Increase (decrease) in valuation allowances 0.9   (0.6)  0.9   0.2    
    Other discrete tax items 0.7   0.9   (4.7)  1.2   1.8 
    Total tax adjustments (C)$1.6  $0.3  $(3.8) $1.4  $1.8 
    Adjusted net earnings (A+B+C)$15.9  $14.1  $63.0  $36.5  $48.1 
                        
    Net sales$132.5  $123.0  $512.9  $424.1  $469.0 
                        
    Adjusted net earnings as a % of net sales 12.0%  11.5%  12.3%  8.6%  10.3%



    Adjusted Diluted Earnings Per Share

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020  2019 
    GAAP diluted earnings (loss) per share$0.28  $0.46  $(1.30) $1.06  $1.09 
    Tax affected charges to reported diluted earnings (loss) per share:                   
    Restructuring charges 0.04   0.01   0.06   0.04   0.18 
    Foreign currency loss (gain) 0.06   (0.10)  0.10   (0.16)  0.05 
    Non-cash pension expense 0.03   0.01   3.13   0.06   0.02 
    Environmental charges 0.03   0.03   0.05   0.07   0.05 
    Transaction costs    0.01      0.01   0.02 
    Legal Settlement             (0.01)
    Discrete tax items 0.05   0.01   (0.11)  0.04   0.05 
    Adjusted diluted earnings per share$0.49  $0.43  $1.93  $1.12  $1.45 



    Debt to Capitalization

     Twelve Months Ended
    December 31,
     
     2021  2020  2019 
    Total debt (A)$50.0  $54.6  $99.7 
    Total shareholders' equity (B)$463.6  $423.7  $405.2 
    Total capitalization (A+B)$513.6  $478.3  $504.9 
    Total debt to capitalization 9.7%  11.4%  19.7%



    Controllable Working Capital

     Twelve Months Ended
    December 31,
     
     2021  2020  2019 
    Net accounts receivable$82.2  $81.0  $78.0 
                
    Net inventory$49.5  $45.9  $42.2 
                
    Accounts payable$(55.5) $(50.5) $(48.2)
                
    Controllable working capital$76.2  $76.4  $72.0 
                
    Quarter sales$132.5  $123.0  $115.0 
    Multiplied by 4 4   4   4 
    Annualized sales$530.1  $492.1  $460.2 
                
    Controllable working capital as a % of annualized sales 14.4%  15.5%  15.7%



    Free Cash Flow

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020  2019 
    Net cash provided by operating activities$26.0  $26.4  $86.1  $76.8  $64.4 
    Capital expenditures (7.5)  (4.4)  (15.6)  (14.9)  (21.7)
    Free cash flow$18.5  $22.0  $70.5  $61.9  $42.7 



    Capital Expenditures

     Three Months Ended
    December 31,
     Twelve Months Ended
    December 31,
     2021  2020  2021  2020  2019 
    Capital expenditures$7.5  $4.4  $15.6  $14.9  $21.7 
    Net sales$132.5  $123.0  $512.9  $424.1  $469.0 
    Capex as % of net sales 5.7%  3.6%  3.0%  3.5%  4.6%



    Additional Information

    The following table includes other financial information not presented in the preceding financial statements.

     Three Months Ended
    December 31,
      Twelve Months Ended
    December 31,
     
     2021  2020  2021  2020 
    Depreciation and amortization expense$6.7  $6.9  $26.9  $26.7 
    Stock-based compensation expense$2.0  $1.3  $6.1  $3.4 


    Primary Logo

Опубликовать